European Hematology Association

Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) has managed to keep sell-side analysts encouraged with its last Friday's presentation at the European Hematology Association meeting. The latest sell-side firm to express its happiness over the data was Raymond James. Analyst Reni Benjamin termed the...

Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) was at its volatile best all this week. After a 14-percent gain Monday, the stock pulled back slightly Tuesday and retreated by less than 2 percent Wednesday. It rallied over 10 percent Thursday, only to slip by about 7 percent Friday amid the Bellicum...

In a new report, analysts at JMP Securities focused on stocks and recent developments in the world of biotechnology. Overall, much of the sector has been under pressure recently from a negative market tone and “puzzling” Endocrinology and Metabolic Drug Advisory Committee (EMDAC)...